Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.
Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.
复制标题
肥胖和正常体重男性间歇服用两次三唑仑后的药代动力学和药效学。
DOI:
--
复制
发表时间:
1995
影响因子:
2.9
通讯作者:
R. Smith
中科院分区:
文献类型:
--
作者:
C. Derry;P. Kroboth;A. Pittenger;F. Kroboth;S. E. Corey;R. Smith
This study was designed to determine whether differences in alpha-1 acid glycoprotein and free drug concentrations result in an altered response to triazolam. Twelve normal-weight and 12 obese adult male subjects received intravenous doses of triazolam, 0.5 mg, on two occasions separated by 1 week. There was a small difference in the alpha-1 acid glycoprotein concentrations between groups but no difference in free fraction of triazolam. There was a longer terminal half-life (t1/2 beta) in the obese subjects (3.16 +/- 0.87 vs. 3.83 +/- 1.24, p = 0.0098). Overall, week 1 data revealed no difference in effect between normal and obese subjects. However, response data reveal a pattern of increased sensitivity with the second exposure to triazolam. For example, area under the effect curve (AUEC) on all tests was significantly greater in week 2 for both groups of subjects. For a memory test and sedation from 0 to 12 hours, AUEC/free AUC ratios were significantly greater in week 2 for all subjects. The obese had a higher ratio on week 2 than on week 1 for all psychomotor tests and sedation (0 to 4.5 hours; p < 0.05). The results of modeling psychomotor impairment-concentration data pooled by group for each week continue the pattern: week 1 data are similar between the obese and normal-weight subjects. Although EC50 values are up to 15% lower in week 2 for the normal-weight subjects, EC50 values are as much as 66% lower in week 2 for the obese, where a lower EC50 indicates greater sensitivity. Logistic regression of the recognition data is consistent with these results.(ABSTRACT TRUNCATED AT 250 WORDS)
DOI:
10.1038/npp.1993.30
发表时间:
1993
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
Byrnes,JJ;Miller,LG;Perkins,K;Greenblatt,DJ;Shader,RI
通讯作者:
Shader,RI
DOI:
10.1016/s0378-4347(00)80261-3
发表时间:
1981
期刊:
Journal of chromatography
影响因子:
--
作者:
Greenblatt,DJ;Divoll,M;Moschitto,LJ;Shader,RI
通讯作者:
Shader,RI